| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||
RESEARCH |
activation disrupts sex organ differentiation and induces expression of vitellogenin II and very low-density apolipoprotein II in Japanese quail embryos
A Mattsson, Environmental Toxicology, Uppsala University, Uppsala, 752 36, Sweden
J Olsson, Environmental Toxicology, Uppsala University, Uppsala, Sweden
B Brunström, Environmental Toxicology, Uppsala University, Uppsala, Sweden
Correspondence: Anna Mattsson, Email: Anna.Mattsson{at}ebc.uu.se
Abstract
The Japanese quail (Coturnix japonica) is a widely-used model species for studying the roles of steroid hormones in avian sex differentiation. The aim of the present study was to elucidate the significance of estrogen receptors alpha and beta (ER
and ERβ) in normal sex differentiation of the reproductive organs in the Japanese quail and in xenoestrogen-induced disruption of reproductive-organ differentiation. Real-time PCR indicated that ER
mRNA is expressed in both right and left gonads and Mullerian ducts in both sexes during early morphological differentiation. ERβ-transcripts were also detected in gonads and Mullerian ducts, but at very low levels. Both receptor subtypes were expressed in the liver and may therefore mediate the expression of estrogen-regulated egg-yolk proteins. Aromatase mRNA was expressed at much higher levels in female than male gonads as early as embryonic day 5, indicating early sex differences in estrogen synthesis. Treatment with the ER
-selective agonist, propyl pyrazole triol (PPT), showed that frequently-reported xenoestrogen effects such as ovotestis formation, abnormal Mullerian duct development, and hepatic expression of egg-yolk proteins were induced by selective activation of ER
. Taken together, our results suggest that activation of ER
is crucial for estrogen-dependent sex differentiation of the reproductive organs and that ER
mediates xenoestrogen-induced toxicity during reproductive development in birds.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |